Alcon
ALC Healthcare Medical Instruments & Supplies
Alcon’s revenue for fiscal 2025 (year ended December 2025) was $10.4 billion, up 4.94% from fiscal 2024.
- Revenue
- +8.74%
- EPS
- −100.0%
- Free cash flow
- −0.54%
- Total debt
- −0.55%
Quarter to June 2026, against a year earlier
Follow ALC
Alert me
Alcon (ALC) Book value per share
Alcon's book value per share at the end of fiscal 2025 was 44.7×, unchanged from fiscal 2024. At the end of the quarter to 30 June 2026 it was 44.4×. Over the past ten years it has ranged from 0.0× (fiscal 2016) to 46.8× (fiscal 2017); the current reading is higher than 80% of that period. Alcon ranks 6th of 52 Medical Instruments & Supplies companies by book value per share.
Book value per share, annual
Embed this chart
Annual newest first
| Period | Book value per share | Change |
|---|---|---|
| FY2025 | 44.7× | 2.48% |
| FY2024 | 43.6× | 4.21% |
| FY2023 | 41.8× | 4.47% |
| FY2022 | 40.0× | 1.90% |
| FY2021 | 39.3× | 2.10% |
| FY2020 | 38.5× | (2.65%) |
| FY2019 | 39.5× | (14.74%) |
| FY2018 | 46.4× | (0.98%) |
| FY2017 | 46.8× | — |
| FY2016 | 0.0× | — |
Quarterly newest first
| Period | Book value per share | Change |
|---|---|---|
| Jun 2026 | 44.4× | (2.33%) |
| Mar 2026 | 45.4× | 1.68% |
| Dec 2025 | 44.7× | (0.24%) |
| Sep 2025 | 44.8× | 0.22% |
| 29 more quarters | Free account |
Against its own ten years
Book value per share against peers
| Company | Book value per share |
|---|---|
| BDX Becton, Dickinson and Company compare | 88.9× |
| ALGN Align Technology, Inc. compare | 60.6× |
| ALC Alcon | 44.4× |
| COO The Cooper Companies, Inc. compare | 43.2× |
| WST West Pharmaceutical Services, Inc. compare | 42.2× |
| RMD ResMed Inc. compare | 41.6× |
| SOLV Solventum Corporation compare | 28.1× |
| MDLN Medline Inc. compare | 22.1× |
| BAX Baxter International Inc. compare | 12.5× |
What Book value per share is
BV per Share tells an investor how much of a company’s accounting net worth stands behind each share.
(Shareholders Equity (Total) ÷ Shares (Basic, Weighted))
More on ALC
- Revenue
- Net income
- EPS (diluted)
- EBITDA
- Free cash flow
- Operating cash flow
- Gross margin
- Operating margin
- Net margin
- Free cash flow margin
- P/E ratio
- P/S ratio
- P/B ratio
- Price to free cash flow
- EV/EBITDA
- EV/Sales
- EV/FCF
- Return on equity
- Return on assets
- Return on invested capital
- Debt to equity
- Current ratio
- Total debt
- Shares outstanding
- Revenue growth
- Piotroski F-score
- Beneish M-score
- The full statement